OSI Systems Q2 22 Earnings Conference Call At 12:00 PM ET

By RTTNews Staff Writer ✉ | Published: 1/27/2022 11:00 AM ET

OSI Systems Inc. (OSIS) will host a conference call at 12:00 PM ET on Jan. 27, 2022, to discuss Q2 22 earnings results.

To access the live webcast, log on to https://investors.osi-systems.com/investor-relations/general-information/events-and-presentations

For comments and feedback contact: editorial@rttnews.com

Business News

Biotech Stocks Facing FDA Decision In October 2022

Biotech Stocks Facing FDA Decision In September

Biotech Stocks Facing FDA Decision In June 2022

Latest Updates on COVID-19

FDA Updates COVID-19 Test Policy; Asks Developers To Seek Premarket Review Pathways

Covid Conditions Improving Nationally In US, Data Shows

Pfizer, BioNTech Apply For EUA In US Of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster In Kids

Synairgen Reports Positive 60 And 90-day Long COVID Data From Phase 3 SNG001 Trial; Stock Up

U.S. Covid Cases Fall 29% In Last Fortnight

COVID-19: Drugs in Development

Ford Hikes Price Of F-150 Lightning Electric Pickup Again

Tyson To Move Corporate Jobs In Chicago, Downers Grove, Dakota Dunes To Arkansas

Virgin Orbit Says Its Latest Rocket Is Ready For Flight

FAA Extends Rest Periods For Flight Attendants

Hilton To Feature Peloton Bikes Across All 5,400 U.S. Hotels

Zerto Fontal Cheese, Brie And Camembert Cheeses Recalled

OSI Systems Q2 22 Earnings Conference Call At 12:00 PM ET

Ford Hikes Price Of F-150 Lightning Electric Pickup Again

Tyson To Move Corporate Jobs In Chicago, Downers Grove, Dakota Dunes To Arkansas

Virgin Orbit Says Its Latest Rocket Is Ready For Flight

FAA Extends Rest Periods For Flight Attendants

Hilton To Feature Peloton Bikes Across All 5,400 U.S. Hotels

Zerto Fontal Cheese, Brie And Camembert Cheeses Recalled

Tesla Q3 Vehicle Production, Deliveries Up

Pineapple Energy Surges More Than 80%

RedHill Says Its Oral Antivirals, Opaganib And RHB-107, Inhibit Dominant Omicron Sub-Variant BA.5

Gilead Company Kite Says FDA Oks RVV Manufacturing Facility In California For Commercial Production

Myovant Sciences Rejects $2.5 Bln Offer From Sumitovant And Sumitomo Pharma

ABB Completes Spin-off Of Accelleron Industries

Clene Reports Topline Results For CNM-Au8 In Healey ALS Platform Trial

Holcim Buys Polymers Sealants North America From Illinois Tool Works

Vodafone In Talks To Merge Its British Arm With Three UK

Revisiting Myovant...

Prosus Reveals Termination Of $4.7 Bln Deal To Buy India's BillDesk

Roche's PATHWAY Anti-HER2 (4B5) Test Gets FDA Approval To Identify Patients Eligible For ENHERTU

Intercontinental Exchange Q3 Total ADV Up 5% YoY - Quick Facts

Prosus Reveals Termination Of $4.7 Bln Deal To Buy India's BillDesk

Porsche Becomes Most Valuable Car Maker In Europe

Quanergy Board Approves Reverse Stock Split - Quick Facts

RS Group Expects Full Year Revenue, Adj. Profit Slightly Ahead Of Consensus Expectations

RPM International Q1 Results Top Estimate; Guides Q2 Sales

Merck Group Says On Track To Hit EUR 25 Bln Sales Target By 2025

Imperial Brands To Start £1Bln Share Buyback, Affirms Trading In Line With View

Chemring Group Says Trading In Line With Expectations

Aquaron Acquisition Prices IPO Of 5 Mln Units At $10.00/unit

Cigna Expands Medicare Advantage Plans For 2023 With 22% Growth In Geographic Footprint

Everi To Buy Certain Strategic Assets Of Venuetize